Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Antihypertensive effects of candesartan cilexetil, enalapril and placebo.

Franke H.

J Hum Hypertens. 1997 Sep;11 Suppl 2:S61-2. No abstract available.

PMID:
9331010
2.

Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.

Zanchetti A, Omboni S, Di Biagio C.

J Hum Hypertens. 1997 Sep;11 Suppl 2:S57-9. No abstract available.

PMID:
9331009
3.
4.

Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group.

Tanser PH, Campbell LM, Carranza J, Karrash J, Toutouzas P, Watts R.

Am J Hypertens. 2000 Feb;13(2):214-8.

PMID:
10701823
5.

Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.

Rosei EA, Rizzoni D, Muiesan ML, Sleiman I, Salvetti M, Monteduro C, Porteri E; CENTRO (CandEsartaN on aTherosclerotic Risk factors) study investigators..

J Hypertens. 2005 Feb;23(2):435-44.

PMID:
15662233
6.
7.

The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.

Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T; Effect Study Group..

Blood Press. 2001;10(1):43-51.

PMID:
11332334
8.

Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan.

Ogihara T, Arakawa K.

J Hum Hypertens. 1999 Jan;13 Suppl 1:S27-31; discussion S33-4. Review.

PMID:
10076918
9.

Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.

Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL.

Am J Cardiol. 1999 Aug 1;84(3):289-93.

PMID:
10496437
10.

A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.

Andersson OK, Neldam S.

J Hum Hypertens. 1997 Sep;11 Suppl 2:S63-4. No abstract available.

PMID:
9331011
11.

Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.

Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL.

Am J Cardiol. 1998 Oct 15;82(8):961-5.

PMID:
9794352
12.
13.

[Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].

Baumgart P, Reismann J, Pohlmeyer H, Düsing R.

Dtsch Med Wochenschr. 2001 May 11;126(19):547-50. German.

PMID:
11402910
14.

Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension.

Heuer HJ, Schöndorfer G, Högemann AM.

J Hum Hypertens. 1997 Sep;11 Suppl 2:S55-6. No abstract available.

PMID:
9331008
15.

Role of the renin-angiotensin system in hypertension in the elderly.

Nagano M, Higaki J, Mikami H, Ogihara T.

Blood Press Suppl. 1994;5:130-3.

PMID:
7889195
16.

Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial.

Association of Black Cardiologists (ABC) Candesartan Study Group..

Heart Dis. 2000 Nov-Dec;2(6):392-9.

PMID:
11728289
17.

The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.

McInnes GT, O'Kane KP, Jonker J, Roth J.

J Hum Hypertens. 1997 Sep;11 Suppl 2:S75-80.

PMID:
9331015
18.

Supplemental Content

Support Center